Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children
Authors:
Open Access
- 19 January 2024
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (6) , 1901-1907
Abstract
Background: Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS) is associated with high morbidity and relevant mortality. Previous small studies showed that volume expansion could improve the course and outcome of STEC-HUS. The aim of this single-center study was to evaluate the effect of volume expansion on the clinical course and outcome in STEC-HUS. Methods: Data of pediatric patients with STEC-HUS were analyzed retrospectively. Course and outcome of patients treated with volume expansion (VE) from 2019 to 2022 (n = 38) were compared to historical controls (HC) from 2009 to 2018 (n = 111). Results: Patients in the VE group had a significant relative median weight gain compared to HC (7.8% (3.4–11.3) vs. 1.2% (− 0.7–3.9), p < 0.0001) 48 h after admission. The need for dialysis was not reduced by VE (VE 21/38 (55.3%) vs. HC 64/111 (57.7%), p = 0.8). However, central nervous system involvement (impairment of consciousness, seizures, focal neurological deficits, and/or visual disturbances) was significantly reduced (VE 6/38 (15.8%) vs. HC 38/111 (34.2%), p = 0.039). None of the patients in the VE group died or developed chronic kidney disease (CKD) stage 5, whereas in the HC group, three patients died and three patients had CKD stage 5 at discharge. Conclusions: This study suggests that volume expansion may be associated with the mitigation of the acute course of STEC-HUS, especially severe neurological involvement and the development of CKD. Prospective trials should lead to standardized protocols for volume expansion in children with STEC-HUS. GraphicalKeywords
Funding Information
- Universitätsklinikum Hamburg-Eppendorf (UKE)
This publication has 23 references indexed in Scilit:
- Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndromePediatric Nephrology, 2014
- Long-term outcomes of Shiga toxin hemolytic uremic syndromePediatric Nephrology, 2013
- An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in ChildrenClinical Infectious Diseases, 2012
- Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome childrenPediatric Nephrology, 2012
- Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging SequelaeClinical Infectious Diseases, 2012
- Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic SyndromeArchives of Pediatrics & Adolescent Medicine, 2011
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Predictors of Fatality in Postdiarrheal Hemolytic Uremic SyndromePediatrics, 2006
- Relative Nephroprotection DuringEscherichia coliO157:H7 Infections: Association With Intravenous Volume ExpansionPediatrics, 2005
- A simple estimate of glomerular filtration rate in adolescent boysThe Journal of Pediatrics, 1985